Latest treatment options for Alzheimer’s disease, Parkinson’s disease dementia and dementia with Lewy bodies
出版年份 2014 全文链接
标题
Latest treatment options for Alzheimer’s disease, Parkinson’s disease dementia and dementia with Lewy bodies
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume 15, Issue 13, Pages 1797-1810
出版商
Informa Healthcare
发表日期
2014-07-03
DOI
10.1517/14656566.2014.936848
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Reductions in Amyloid-β-Derived Neuroinflammation, with Minocycline, Restore Cognition but do not Significantly Affect Tau Hyperphosphorylation
- (2017) Anna Parachikova et al. JOURNAL OF ALZHEIMERS DISEASE
- Emerging Therapeutics for Alzheimer's Disease
- (2014) Karen Chiang et al. Annual Review of Pharmacology and Toxicology
- Normalizing Effects of EVP-6124, an Alpha-7 Nicotinic Partial Agonist, on Event-Related Potentials and Cognition
- (2014) SHELDON H. PRESKORN et al. Journal of Psychiatric Practice
- Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy
- (2014) Tara L. Spires-Jones et al. NEUROSCIENCE LETTERS
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?
- (2014) Fares Bassil et al. PROGRESS IN NEUROBIOLOGY
- The worldwide economic impact of dementia 2010
- (2013) Anders Wimo et al. Alzheimers & Dementia
- Tau-aggregation inhibitor therapy for Alzheimer's disease
- (2013) Claude M. Wischik et al. BIOCHEMICAL PHARMACOLOGY
- Is a potential Alzheimer's therapy already in use for other conditions? Can medications for hypertension, diabetes and acne help with the symptoms?
- (2013) Anne Corbett et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Suppression of eIF2α kinases alleviates Alzheimer's disease–related plasticity and memory deficits
- (2013) Tao Ma et al. NATURE NEUROSCIENCE
- Semagacestat for Treatment of Alzheimer's Disease
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- The novel BACE inhibitor MK-8931 dramatically lowers cerebrospinal fluid Aβ peptides in healthy subjects following single- and multiple-dose administration
- (2012) Mark Forman et al. Alzheimers & Dementia
- Donepezil for dementia with Lewy bodies: A randomized, placebo-controlled trial
- (2012) Etsuro Mori et al. ANNALS OF NEUROLOGY
- Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
- (2012) Vladimir Coric et al. ARCHIVES OF NEUROLOGY
- EHT0202 in Alzheimers Disease: A 3-Month, Randomized, Placebo- Controlled, Double-Blind Study
- (2012) B. Vellas et al. Current Alzheimer Research
- Clinical Trials of Dementia With Lewy Bodies and Parkinson’s Disease Dementia
- (2012) D. Aarsland et al. Current Neurology and Neuroscience Reports
- β-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment
- (2012) Jun Cai et al. EMBO Molecular Medicine
- Sustained levels of antibodies against Aβ in amyloid-rich regions of the CNS following intravenous dosing in human APP transgenic mice
- (2012) Frédérique Bard et al. EXPERIMENTAL NEUROLOGY
- New and emerging treatments for Alzheimer's disease
- (2012) Anne Corbett et al. EXPERT OPINION ON EMERGING DRUGS
- An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers
- (2012) Theresa R. Bomfim et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
- (2012) Bengt Winblad et al. LANCET NEUROLOGY
- The Lewy Body in Parkinson’s Disease and Related Neurodegenerative Disorders
- (2012) Koichi Wakabayashi et al. MOLECULAR NEUROBIOLOGY
- A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
- (2012) Thorlakur Jonsson et al. NATURE
- Drug repositioning for Alzheimer's disease
- (2012) Anne Corbett et al. NATURE REVIEWS DRUG DISCOVERY
- Chronic Divalproex Sodium to Attenuate Agitation and Clinical Progression of Alzheimer Disease
- (2011) Pierre N. Tariot ARCHIVES OF GENERAL PSYCHIATRY
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment
- (2011) Suzanne Craft ARCHIVES OF NEUROLOGY
- Influence of Lithium Treatment on GDNF Serum and CSF Concentrations in Patients with Early Alzheimers Disease
- (2011) Guido Straten et al. Current Alzheimer Research
- Treatment of Dementia with Lewy Bodies and Parkinsonʼs Disease Dementia
- (2011) Clive Ballard et al. DRUGS & AGING
- Aligning the evidence with practice: NICE guidelines for drug treatment of Alzheimer’s disease
- (2011) Clive Ballard et al. Expert Review of Neurotherapeutics
- O4-4.5 Associations of angiotensin-II receptor blockers and ACE inhibitors with Alzheimer's disease: a nested case-control study within the UK general practice research database
- (2011) N. Davies et al. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
- The Second-Generation Active A Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects
- (2011) C. Wiessner et al. JOURNAL OF NEUROSCIENCE
- Alzheimer's disease
- (2011) Clive Ballard et al. LANCET
- A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes
- (2011) Olivier Rascol et al. LANCET NEUROLOGY
- The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double-blind, placebo-controlled, multicenter study
- (2011) Hasmet A. Hanagasi et al. MOVEMENT DISORDERS
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
- (2011) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors
- (2011) Jos Prickaerts et al. NEUROPHARMACOLOGY
- Brain renin-angiotensin—A new look at an old system
- (2011) John W. Wright et al. PROGRESS IN NEUROBIOLOGY
- Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue
- (2011) Julio C. Rojas et al. PROGRESS IN NEUROBIOLOGY
- Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial
- (2011) François Piette et al. Alzheimers Research & Therapy
- Anti-TNF-α reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains
- (2010) Jian-Quan Shi et al. BRAIN RESEARCH
- Effects of Cholinesterase Inhibitors in Parkinson's Disease Dementia: A Review of Clinical Data
- (2010) Teus van Laar et al. CNS Neuroscience & Therapeutics
- Retinoic acid receptor-α signalling antagonizes both intracellular and extracellular amyloid-β production and prevents neuronal cell death caused by amyloid-β
- (2010) C. I. Jarvis et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Demonstration of safety in Alzheimer's patients for intervention with an anti-hypertensive drug Nilvadipine: results from a 6-week open label study
- (2010) S. P. Kennelly et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study
- (2010) Gareth Maher-Edwards et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats
- (2010) Jorn Arnt et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Reduced Sodium Channel Nav1.1 Levels in BACE1-null Mice
- (2010) Doo Yeon Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Alzheimer's disease: clinical trials and drug development
- (2010) Francesca Mangialasche et al. LANCET NEUROLOGY
- Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial
- (2010) Murat Emre et al. LANCET NEUROLOGY
- Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies
- (2010) Craig Anderson et al. LANCET NEUROLOGY
- Early-Stage Inflammation and Experimental Therapy in Transgenic Models of the Alzheimer-Like Amyloid Pathology
- (2010) A.C. Cuello et al. Neurodegenerative Diseases
- Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease
- (2010) D. Weintraub et al. NEUROLOGY
- Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe
- (2010) H. H. Feldman et al. NEUROLOGY
- Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders
- (2009) Bruno Vellas et al. Current Alzheimer Research
- Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: A link between diabetes and Alzheimer's disease
- (2009) Paula L. McClean et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The serotonin 5-HT6receptor: a viable drug target for treating cognitive deficits in Alzheimer’s disease
- (2009) Werner J Geldenhuys et al. Expert Review of Neurotherapeutics
- Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled Trial
- (2009) Robert C. Green JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
- (2009) Dag Aarsland et al. LANCET NEUROLOGY
- Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice
- (2009) Xin-Kang Tong et al. NEUROBIOLOGY OF DISEASE
- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
- (2009) C. Warren Olanow et al. NEW ENGLAND JOURNAL OF MEDICINE
- O3-04-07: Tau aggregation inhibitor (TAI) therapy with rember™ arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks
- (2008) Claude M. Wischik et al. Alzheimers & Dementia
- Efficacy of a Vitamin/Nutriceutical Formulation for Moderate-stage to Later-stage Alzheimer's disease: A Placebo-controlled Pilot Study
- (2008) Ruth Remington et al. American Journal of Alzheimers Disease and Other Dementias
- Phase 2 Safety Trial Targeting Amyloid β Production With a γ-Secretase Inhibitor in Alzheimer Disease
- (2008) Adam S. Fleisher et al. ARCHIVES OF NEUROLOGY
- Etazolate, a neuroprotective drug linking GABAAreceptor pharmacology to amyloid precursor protein processing
- (2008) Maryline Marcade et al. JOURNAL OF NEUROCHEMISTRY
- Retinoic Acid Attenuates -Amyloid Deposition and Rescues Memory Deficits in an Alzheimer's Disease Transgenic Mouse Model
- (2008) Y. Ding et al. JOURNAL OF NEUROSCIENCE
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies
- (2008) Jennifer G. Goldman et al. MOVEMENT DISORDERS
- Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: A pilot open-label study
- (2008) Laura Marsh et al. MOVEMENT DISORDERS
- Amyloid β concentrations in older people with Down syndrome and dementia
- (2008) Emma L. Jones et al. NEUROSCIENCE LETTERS
- No Effect of One-Year Treatment with Indomethacin on Alzheimer's Disease Progression: A Randomized Controlled Trial
- (2008) Daniëlle de Jong et al. PLoS One
- BACE1 gene deletion: Impact on behavioral function in a model of Alzheimer's disease
- (2007) Dione Kobayashi et al. NEUROBIOLOGY OF AGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now